The federal panel that opposed prostate cancer screening just changed its mind

An influential federal task force has dropped its controversial opposition to routine screening for prostate cancer and now says that men between the ages of 55 and 69 should discuss the test’s potential benefits and harms with their doctors and make decisions based on their own “values and preferences.” “The decision about whether to be […]Related:Physician recommendations about breast cancer screening vary, survey findsSurvey shows why doctors choose medicine and the challenges they faceDeep brain stimulation may reduce severe Tourette’s syndrome
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news